Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Naoki Nagata

Showing results (31-40 of 85) with videos related to

Pageof 9
Sort By:
Diseases of the Colon and Rectum|December 14, 2006
Lymphatic microvessel density is an independent prognostic factor in colorectal cancerKentaro Matsumoto, Yoshifumi Nakayama, Yuzuru Inoue, et al.
Anticancer Research|January 10, 2014
Prospective phase II trial of second-line FOLFIRI in patients with advanced colorectal cancer including analysis of UGT1A1 polymorphisms: FLIGHT 2 studyKeiji Hirata, Naoki Nagata, Takeshi Kato, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 23, 2011
[A case of pathological complete response after treatment with uracil/tegafur (UFT) and folinate (Leucovorin) for liver metastasis of colon cancer]Ryouta Murayama, Naoki Nagata, Shinsaku Honda, et al.
Anticancer Research|January 30, 2003
Relationships between tumor-associated macrophages and clinicopathological factors in patients with colorectal cancerYoshifumi Nakayama, Nobuo Nagashima, Noritaka Minagawa, et al.
Asia-Pacific Journal of Clinical Oncology|October 2, 2018
The prognostic significance of the expression of monocarboxylate transporter 4 in patients with right- or left-sided colorectal cancerYukio Abe, Yoshifumi Nakayama, Takefumi Katsuki, et al.
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology|December 11, 2024
[Squamous cell carcinoma of the gallbladder with direct invasion to adjacent organs:a case report]Atsushi Toyofuku, Masaya Bando, Koichi Nakamura, et al.
Clinical Colorectal Cancer|August 11, 2016
A Phase II Study of XELOX and Cetuximab as First-Line Therapy in Patients With KRAS Wild Type Metastatic Colorectal Cancer (FLEET2 Study)Shoichi Hazama, Hiromichi Maeda, Shigeyoshi Iwamoto, et al.
Journal of UOEH|September 11, 2022
A Case Report of Primary Unresectable Hilar Cholangiocarcinoma Causing Colonic Obstruction Due to Peritoneal DisseminationAtsushi Toyofuku, Hiroaki Kuroda, Kazuma Ito, et al.
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology|November 10, 2024
[Poorly differentiated hepatocellular carcinoma with sarcomatous change causing intraparenchymal rupture and rapid turnaround: a case report]Atsushi Toyofuku, Hiroaki Kuroda, Masaya Bando, et al.
Anticancer Research|December 12, 2003
Relationships between S-100 protein-positive cells and clinicopathological factors in patients with colorectal cancerYoshifumi Nakayama, Yuzuru Inoue, Noritaka Minagawa, et al.
Pageof 9

Showing results (31-40 of 85) with videos related to

Sort By:
Pageof 9
Diseases of the Colon and Rectum|December 14, 2006
Lymphatic microvessel density is an independent prognostic factor in colorectal cancerKentaro Matsumoto, Yoshifumi Nakayama, Yuzuru Inoue, et al.
Anticancer Research|January 10, 2014
Prospective phase II trial of second-line FOLFIRI in patients with advanced colorectal cancer including analysis of UGT1A1 polymorphisms: FLIGHT 2 studyKeiji Hirata, Naoki Nagata, Takeshi Kato, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 23, 2011
[A case of pathological complete response after treatment with uracil/tegafur (UFT) and folinate (Leucovorin) for liver metastasis of colon cancer]Ryouta Murayama, Naoki Nagata, Shinsaku Honda, et al.
Anticancer Research|January 30, 2003
Relationships between tumor-associated macrophages and clinicopathological factors in patients with colorectal cancerYoshifumi Nakayama, Nobuo Nagashima, Noritaka Minagawa, et al.
Asia-Pacific Journal of Clinical Oncology|October 2, 2018
The prognostic significance of the expression of monocarboxylate transporter 4 in patients with right- or left-sided colorectal cancerYukio Abe, Yoshifumi Nakayama, Takefumi Katsuki, et al.
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology|December 11, 2024
[Squamous cell carcinoma of the gallbladder with direct invasion to adjacent organs:a case report]Atsushi Toyofuku, Masaya Bando, Koichi Nakamura, et al.
Clinical Colorectal Cancer|August 11, 2016
A Phase II Study of XELOX and Cetuximab as First-Line Therapy in Patients With KRAS Wild Type Metastatic Colorectal Cancer (FLEET2 Study)Shoichi Hazama, Hiromichi Maeda, Shigeyoshi Iwamoto, et al.
Journal of UOEH|September 11, 2022
A Case Report of Primary Unresectable Hilar Cholangiocarcinoma Causing Colonic Obstruction Due to Peritoneal DisseminationAtsushi Toyofuku, Hiroaki Kuroda, Kazuma Ito, et al.
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology|November 10, 2024
[Poorly differentiated hepatocellular carcinoma with sarcomatous change causing intraparenchymal rupture and rapid turnaround: a case report]Atsushi Toyofuku, Hiroaki Kuroda, Masaya Bando, et al.
Anticancer Research|December 12, 2003
Relationships between S-100 protein-positive cells and clinicopathological factors in patients with colorectal cancerYoshifumi Nakayama, Yuzuru Inoue, Noritaka Minagawa, et al.
Pageof 9